Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas

Purpose: Loco-regional control and organ preservation are significantly improved with concomitant cisplatin/radiotherapy and are compromised with less than 5% grade 3 nephrotoxicity (creatinine clearance 15–29 mL/min). However, although clinically important, in none of the randomized trials is grade...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoek, Jantien, Bloemendal, Karen M., van der Velden, Lilly-Ann A., van Diessen, Judi N.A., van Werkhoven, Erik, Klop, Willem M.C., Tesselaar, Margot E.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773744/
https://www.ncbi.nlm.nih.gov/pubmed/26891330
http://dx.doi.org/10.3390/cancers8020021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773744/
https://www.ncbi.nlm.nih.gov/pubmed/26891330
http://dx.doi.org/10.3390/cancers8020021

Ejemplares similares